Close

BrainScan SA

ul. Kieturakisa 10
80-742 Gdansk
Poland
VAT-ID: PL 5862321880

We revolutionized the analysis of human brain ct scans through AI.

Read more
EU Grants
Solution
Latest News
Evidence
/ We revolutionized the analysis of human brain ct scans through AI. 
/ We revolutionized the analysis of human brain ct scans through AI. 

Presentation of Results

Abnormality presence
Detected findings
Available findings locations
Results infographic

EU GrantsBrainScan Receives SMART Pathway Funding from Polish Agency for Enterprise Development

BrainScan S.A. has received €2.64 million in funding from the Polish Agency for Enterprise Development under the SMART Pathway program (FENG.01.01-IP.02-002/23). The project, titled “Multimodal system for automated diagnosis support of brain pathologies in computed tomography,” is valued at approximately €3.81 million (at an approximate exchange rate of 1 EUR = 4.2 PLN) and will run from Q1 2025 to Q2 2027.

The goal is to enhance BrainScan CT with new capabilities, including the analysis of contrast-enhanced CT scans, detection of tumors, and improved diagnostic precision. This grant marks a major step toward advancing BrainScan’s AI-powered platform and scaling its adoption in international markets.

in funding
€ 0 M
Project valuation
€ 0 M
Science

historyCompany History and Strategic Plans

2025
FDA Certification, U.S. Patent, and International Research Collaborations

In 2025, BrainScan targets FDA certification and U.S. patent approval, enabling entry into the American medical market and reinforcing its innovation leadership. The company also continues scientific research in collaboration with the Provincial Hospital in Poznan and LMU Hospital in Munich. These partnerships support clinical validation and help refine upcoming features, including automated report generation planned for 2026 to streamline radiologists' workflows.

2024
30 Brain Pathologies Detected and First On-Premise Deployment

In 2024, BrainScan expanded its AI capabilities to detect 30 key brain pathologies, making it one of the most comprehensive tools in neuroimaging. The company also completed its first full on-premise installation, offering hospitals full data control and local AI-powered diagnostics.

2023
First EU Launch and CE MDR Approval

In 2023, BrainScan completed its first implementation in a European hospital outside Poland. That same year, the company received CE MDR 2017/745 certification, enabling full compliance with updated EU medical device regulations.

2018-2021
CE Certification and RSNA Gold Medal

Between 2018 and 2021, BrainScan received CE certification for its AI-powered diagnostic system. The company also won the Gold Medal at RSNA in the U.S., confirming its global innovation leadership in radiology AI solutions.

2017
Establishing Company

BrainScan was founded in 2017 to revolutionize brain CT diagnostics using AI. The company began developing its own deep learning system for detecting critical brain pathologies in CT scans, setting the foundation for future clinical use and certification.

partnersTrusted collaborators and partners

get in touchWe are always ready to help you and answer your questions

BrainScan SA
office:

ul. Kieturakisa 10
80-742 Gdansk
Poland
VAT-ID: PL5862321880

Email:

contact@brainscan.ai

BrainScan SA
software development center:

ul. Traugutta 75
80-221 Gdansk
Poland

Social networks:
Linkedin-in Youtube